Therapeutic Drug Monitoring and Population Pharmacokinetic Analysis of Teicoplanin among Chinese Patients with Gram-Positive Infections in a Tertiary Hospital

被引:0
|
作者
Li, Yuan-Yuan [1 ,2 ]
Zhang, Guan-Xuan-Zi [1 ,2 ]
Wang, Jin [1 ]
Bai, Nan [1 ]
Cai, Yun [1 ]
机构
[1] Peoples Liberat Army Gen Hosp, Med Supplies Ctr, Ctr Med Clin Res, Dept Pharm, Beijing, Peoples R China
[2] PLA Med Sch, Beijing, Peoples R China
关键词
GUIDELINES; EFFICACY; SAFETY;
D O I
10.1155/2023/2681979
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background. To explore the use of teicoplanin among Chinese patients with Gram-positive infections in a tertiary hospital. Methods. The medical records of patients, who were monitored for teicoplanin plasma concentration (TPC) from December 2017 to February 2019, were collected. By combining the therapeutic drug monitoring (TDM) and nonlinear mixed-effects model, a population pharmacokinetic (PPK) model of teicoplanin was established. Results. The proportions of TPCs lower and higher than 10 mg/L were nearly the same (102 vs. 108 cases). A two-compartment model of teicoplanin PPK in Chinese patients was established. Compared with 400 mg, the 600 mg regimen was more able to reach the target concentration (10 mg/L), especially for high-weight patients. Conclusions. The standard regimen of teicoplanin, 400 mg, failed to reach the target value in the present population. Moreover, the 600 mg regimen was feasible for high-weight patients based on TDM and individualized pharmacokinetic dosing adjustment.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Cost effectiveness analysis of linezolid vs. teicoplanin for the treatment of serious gram-positive bacterial infections in a multinational randomized trial
    Li, JZ
    Willke, RJ
    Balan, DA
    Nathwani, D
    López, H
    Rittenhouse, BE
    Tavacoli, M
    Mozaffari, E
    VALUE IN HEALTH, 2003, 6 (03) : 259 - 260
  • [32] PREVENTION OF GRAM-POSITIVE INFECTIONS IN PERITONEAL DIALYSIS PATIENTS - A COST-EFFECTIVENESS ANALYSIS
    You, J.
    Wong, C.
    Luk, I
    Ip, M.
    VALUE IN HEALTH, 2013, 16 (07) : A358 - A358
  • [33] Modeling Approach to Optimizing Dose Regimen of Vancomycin for Chinese Pediatric Patients with Gram-Positive Bacterial Infections
    Shen, Kai
    Fan, Yaxin
    Yang, Minjie
    Chen, Yuancheng
    Tao, Jinhao
    Lu, Guoping
    Zhang, Hong
    Huang, Qiwei
    Zhang, Jing
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [34] Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico:: Results from a multicenter trial
    López, H
    Li, JZ
    Balan, DA
    Willke, RJ
    Rittenhouse, BE
    Mozaffari, E
    Vidal, G
    Zitto, T
    Tang, T
    CLINICAL THERAPEUTICS, 2003, 25 (06) : 1846 - 1871
  • [35] Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections
    Cattaneo, Dario
    Orlando, Giovanna
    Cozzi, Valeria
    Cordier, Laura
    Baldelli, Sara
    Merli, Stefania
    Fucile, Serena
    Gulisano, Cecilia
    Rizzardini, Giuliano
    Clementi, Emilio
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (06) : 586 - 589
  • [36] Real-world experience of therapeutic drug monitoring and PK/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive bacteria
    Fresan, Daniel
    Luque, Sonia
    Benitez-Cano, Adela
    Sorli, Luisa
    Montero, Maria Milagro
    De-Antonio, Marta
    Vega, Victoria
    Roberts, Jason A.
    Horcajada, Juan P.
    Grau, Santiago
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (12) : 2810 - 2815
  • [37] Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
    Wang, Peile
    Zhang, Qiwen
    Zhu, Zhenfeng
    Feng, Min
    Sun, Tongwen
    Yang, Jing
    Zhang, Xiaojian
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [38] Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection
    Wei, W-X.
    Qin, X-L.
    Cheng, D-H.
    Lu, H.
    Liu, T-T.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (06) : 650 - 656
  • [39] Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
    Kim, Eun Jung
    Oh, Jaeseong
    Lee, Kyounghoon
    Yu, Kyung-Sang
    Chung, Jae-Yong
    Hwang, Joo-Hee
    Nam, Eun Young
    Kim, Hyoung Sook
    Kim, Moonsuk
    Park, Jeong Su
    Song, Young-Ho
    Kim, Eu Suk
    Song, Junghan
    Kim, Hong Bin
    THERAPEUTIC DRUG MONITORING, 2019, 41 (01) : 102 - 106
  • [40] Distribution and Antimicrobial Susceptibility of Gram-Positive and Gram-Negative Pathogens Isolated from Patients Hospitalized in a Tertiary Teaching Hospital in Southwestern China
    Xu, Lingling
    Zeng, Zhangrui
    Ding, Yinhuan
    Song, Min
    Yang, Kui
    Liu, Jinbo
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2020, 13 (12)